A New Method to Predict the Quality of Umbilical Cord Blood Units based on Maternal and Neonatal Factors and Collection Techniques.

Autor: Jamshidi, Rasoul, Sanati, Sattar Rajabpour, Zarrabi, Morteza

Publikováno v: Journal of Applied Research on Industrial Engineering; Jun2023, Vol. 10 Issue 2, p218-237, 20p

Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice.

Autor: Gohil D; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Training School Complex, Homi Bhabha National Institute, Mumbai, India., Gandhi KA; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Training School Complex, Homi Bhabha National Institute, Mumbai, India., Gupta SK; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Training School Complex, Homi Bhabha National Institute, Mumbai, India., Gera P; ICGC Lab, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Biorepository, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Yadav S; Training School Complex, Homi Bhabha National Institute, Mumbai, India.; Department of Pathology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Patwardhan R; Training School Complex, Homi Bhabha National Institute, Mumbai, India.; Radiation Biology & Health Science Division, Bio-science group, Bhabha Atomic Research Centre, Mumbai, India., Checker R; Training School Complex, Homi Bhabha National Institute, Mumbai, India.; Radiation Biology & Health Science Division, Bio-science group, Bhabha Atomic Research Centre, Mumbai, India., Sharma D; Training School Complex, Homi Bhabha National Institute, Mumbai, India.; Radiation Biology & Health Science Division, Bio-science group, Bhabha Atomic Research Centre, Mumbai, India., Khattry N; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Sandur S; Training School Complex, Homi Bhabha National Institute, Mumbai, India.; Radiation Biology & Health Science Division, Bio-science group, Bhabha Atomic Research Centre, Mumbai, India., Gota V; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Training School Complex, Homi Bhabha National Institute, Mumbai, India.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2024 Apr 07. Date of Electronic Publication: 2024 Apr 07.

Myeloablative Versus Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis.

Autor: Sharma, Sanjeev Kumar, Choudhary, Dharma, Doval, Divya, Khandelwal, Vipin, Patel, Amee, Setia, Rasika, Dadu, Tina, Handoo, Anil

Publikováno v: Indian Journal of Hematology & Blood Transfusion; Jul2021, Vol. 37 Issue 3, p472-478, 7p

Guía de Práctica Clínica para el manejo de pacientes con Leucemia Linfoblástica Aguda en el Seguro Social del Perú (EsSalud). (Spanish)

Autor: Rojas Soto, Ninoska, Moreno Larrea, Mariela, Pizarro Perea, Marlies, Aranda Gomero, Lourdes, Arteta Altamirano, Cecilia, Eyzaguirre Zapata, Renee, Goicochea-Lugo, Sergio, Nieto-Gutierrez, Wendy, Garcia-Solorzano, Franko O., Taype-Rondan, Alvaro, Timaná Ruiz, Raúl

Publikováno v: Acta Médica Peruana; Jan-Mar2021, Vol. 38 Issue 1, p64-78, 15p

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.

Autor: Daher-Reyes G; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Kim T; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Department of Computer Science, University of Toronto, Toronto, ON, Canada.; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada., Novitzky-Basso I; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Kim KH; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea., Smith A; Clinical Lab Genetics Division, Laboratory of Molecular Pathology, Toronto General Hospital, University Health Network, Toronto, ON, Canada., Stockley T; Clinical Lab Genetics Division, Laboratory of Molecular Pathology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, Toronto, ON, Canada., Capochichi JM; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, Toronto, ON, Canada., Al-Shaibani Z; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Pasic I; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Law A; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Lam W; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Michelis FV; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Gerbitz A; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Viswabandya A; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Lipton J; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Kumar R; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Mattsson J; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Schimmer A; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., McNamara C; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Murphy T; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Maze D; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Gupta V; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Sibai H; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Chan S; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Yee K; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Minden M; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Zhang Z; Department of Computer Science, University of Toronto, Toronto, ON, Canada.; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Schuh A; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Kim DDH; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. dr.dennis.kim@uhn.ca.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Aug; Vol. 56 (8), pp. 1908-1918. Date of Electronic Publication: 2021 Mar 25.